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The B subunit of DNA gyrase formed two-dimensional crystals when bound to a specIfically recognized phospholrpld spread mto a monolayer 
at the air/water interface. The especially deslgned hplds consisted of novoblocm coupled through the 3’ or 2” hydroxyl group and a hydrophdous 
hnker of a given length to dloleoylphosphatldic acid. Two-dlmenslonal crystals of the gyrase B subumt are formed under physlologlcal condltlons 
of pH and lomc strength, with no precipitant added to the solution. Crystal ddfractlon extended to a 2 7 nm resolutmn m negative stam. with 
unit cell parameters a = 6 1 nm. h = 7.6 nm and 7 = 64 
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1. INTRODUCTION 
DNA topoisomerases are enzymes that control and 
modify the topological state of DNA and play a crucial 
role in determining the function of DNA in cells. These 
enzymes catalyze many conversions between different 
topoisomers of DNA [l-4]. DNA gyrase is a pro- 
karyotic type II topoisomerase and is distinct from 
other topoisomerases in being able to convert relaxed 
circular DNA to a superhelical form. The energy need- 
ed for the conversion is supplied by ATP hydrolysis. 
The enzyme was first isolated from E. cofi [5] and has 
also been detected in other organisms [6,7]. It catalyses 
a number of reactions such as negative supercoiling of 
close circular duplex DNA (ATP dependent), relaxa- 
tion of superhelical DNA (in absence of ATP), in- 
troduction of double strand breaks at specific sites in 
DNA (promoted by oxolinic acid), hydrolysis of ATP 
(DNA dependent) and formation and resolution of 
catenated and knotted duplex DNA. 
DNA gyrase is an AzB2 tetramer [8,9]. Subunit A has 
a molecular mass of 105000 Da and is encoded by the 
nal A gene while subunit B, whose molecular mass is 
95000 Da, is produced by the cou gene [lo]. DNA 
gyrase is inhibited by two classes of antibiotics. The 
first one, including nalidixic and oxolinic acids and 
analogs, acts directly on the gyrase A subunit that 
mediates the ability of the enzyme to introduce and re- 
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join double strand breaks in DNA [ 1 l- 131. The target 
of the second class of antibiotics, of which are coumer- 
mycin Al and novobiocin, is the gyrase B subunit. 
These drugs interact competitively with ATP and pre- 
vent energy transduction [ 10,14-161. Both A and B 
subunits are required to reconstitute the full enzyme ac- 
tivity [8]. 
Recently, direct observation by electron microscopy 
of the gyrase A subunit dimer, of the B subunit 
monomer, of the holoenzyme and of its complex with 
DNA were reported [17]. Authors showed that the uni- 
que shapes of the AzB2 tetramer and of the A2 dimer 
make it possible to deduce the relative locations of the 
subunits in the holoenzyme and to indicate a plausible 
path of the DNA segment in the gyrase DNA complex. 
Images of these complexes were obtained by spraying 
the enzyme onto mica and further contrast enhance- 
ment visualized by rotary shadowing with platinum. A 
three-dimensional computer simulation of gyrase was 
obtained by direct-space reconstruction of the Pt 
shadowed outline of the molecule. The effective resolu- 
tion was limited to about 30 A and was affected by Pt 
grain size and distortions of adsorbed molecules to 
mica. 
This report concerns the preliminary results obtained 
in two-dimensional crystallization of the gyrase B 
subunit at the interface between a solution of the pro- 
tein and monolayers containing novobiocin derivatized 
phospholipids, specifically recognized by this protein. 
The two-dimensional crystallization technique was in- 
troduced in 1983 [18] and since that, appears to be 
more and more powerful, due to the developments in 
the design of the lipid structures, in electron 
microscopy techniques and image processing. 
2. MATERIALS AND METHODS 
Different novobiocin derivatized phospholipids were designed and 
synthesized for this study (Scheme I), accounting for considerations 
of monolayers stability and fluidity, affinity of the gyrase B subunit 
for the novobiocin derivatives and accessibility of the modified drug 
for the protein [19]. 
Stability and fluidity of phospholipid monolayers are essentially 
governed by the nature of the acyl chains on the glycerol backbone. 
According to previous results [20], dioleoyl chains appeared to pro- 
vide the monolayers made of these lipids with enough stability and 
fluidity. Such monolayers are in a fluid phase between 4 and 37°C. 
which ts convenient when working with biologtcal material. 
The way novobiocin is attached to the lipid is decisive for the af- 
finity of the gyrase B subunit towards the ligand. Fragmentary results 
of the literature concerning the affinity of the protein for novobiocin 
derivattves [21] led us to link the antibiotic to the liptd in two dif- 
ferent manners (through the 3’ and 2’ ’ positions, Fig. 1). However 
high the affinity of the protein for the modified drug bound to the 
phospholipid can be, the accessibility of the ligands seems to remain 
a crucial point in obtaining high quality protein arrays. That ac- 
cessibility is directly dependent on the length of the spacer between 
the hpid and the drug and is increased from compounds 11 and 111 to 
I4 and 111. 
The gyrase B subunit was purified from the overexpressmg strain 
N48301pMK461 [22], following essentially the procedures previously 
described [16,23]. A Prr phosphocellulose chromatography [24] was 
inserted after the Polymin P fractionation. The purity of the subunit 
was assayed by SDS gel electrophoresis and supercoiling activity in 
the presence of 5 ng of pure gyrase A subunit [22]. The gyrase B 
subunit was stable in our experimental conditions for more than two 
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days as it was controlled through the DNA supercoiling activity of the 
reconstructed AzBz tetramer. 
Typically, a solution of the protein of interest (17 pl, 100 to 
250pg/ml) in buffer A (5% glycerol, 50 mM Tris pH 7.5, 1 mM 
EDTA, 5 mM DTT) was placed in a small teflon well (4 mm 
diameter, 1 mm deep). The novobiocin linked phospholipid (0.5 to 
0.75 81, 0.5 mg/ml in chloroform/hexane/methanol, 5 : 6 : 1 by vol.) 
was spread on the surface of the aqueous solution and the whole 
device was sealed and stored in the dark to prevent water evapora- 
tion. The protein arrays were allowed to form over periods ranging 
from a few minutes to several days at room temperature. The 
monolayers containing presumably arrays of protein were picked up 
on carbon coated electron microscope grids, negatively stained with 
uranyl formate and exammed in a Philips 300 electron microscope. 
Micrographs were taken at a magnification of 45000 x , using 60 kV 
electrons. 
The original micrographs were digitized on the microdensitometer 
developed by the GSTS (Groupement Scientifique de Teledetection 
Spatiale) and the SERTIT (Service Regional de Traitement d’Image 
et de Teledetection) at 25 pm raster size producing a pixel spacing of 
0.55 nm. The image processing was performed using the IMAGIC 
software kindly provided by M. van Heel [25], which was adapted to 
the SUN-UNIX environment. 
Crystal Images were stored as 1024 x 1024 points and the most 
coherent 256 x 256 areas were selected and multiplied by a smooth 
edged circular mask of 128 pixels in diameter. Fourier transforms 
were calculated for these masked areas and displayed as power spec- 
tra. Strong peaks were interactively selected and used to calculate the 
reciprocal lattice. Amplitude and phase of the peaks having 
amplitudes at least 1.5 times above background and falling on the 
reciprocal lattice were selected from the Fourier transform. A filtered 
image was then calculated by back-Fourier transforming the masked- 
off peaks. The filtered image was centered on a putattve two-fold 
symmetry axis by aligning translationally the filtered image against 
wrth its 180” rotational transform. 
IIn 
Scheme 1. Novobiocin linked phospholipids used to get two-dimensional crystals of the gyrase B subunit. 
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3. RESULTS AND DISCUSSION 
Two-dimensionaf crystals of gyrase B subunit bound 
to a lipid monolayer were formed after a minimum in- 
cubation time of 5 h. The size and coherence of 
crystal&e areas gradually grew over the period of in- 
cubation. However, over 48 h the quality of the crystals 
could not be improved any more. Crystals were obtain- 
ed using protein purified according to different pro- 
cedures, with various purity grades (3040%) and at 
different concentrations (50-250 pug/ml). 
When egg phosphatidyl choline was spread onto a 
monolayer onto a buffer A solution containing the 
gyrase B subunit, some protein was adsorbed on the 
Iipid film but it never gave any ordered array of 
macromoIecuIes. The adsorption was completely avoid- 
ed by increasing the ionic strength of the solution (KC1 
500 mM). Using novobiocin linked phospholipids, pro- 
teins still bound to the film wirh KC1 concentrations up 
to 2 M. However, no two-dimensional crystal of the 
gyrase B subunit was obtained over KC1 300 mM. With 
poorly purified protein (301110 pure), crystals were ob- 
tained using protein concentrations up to 2OOpgimi 
whereas highly pure protein (90% pure) gave ordered 
arrays even at 50 pug/ml. From these observations, we 
can con&de that the gyrase B subunit specifically 
Fig. 1. Partial view of a micrograph showing a negatively stained two-dimenaonal crystal of the gyrase B subunit. This array was obtained using 
a protein emcentration of 250 pgimt in lS@i’o glycerol, 150 mM Ktl, 50 mM Tris (pI_f 7 5). 5 mM DTT and 1 mh4 ERIA, after 24 h l~cuba~lon 
at 20°C. Bar = 100 nm. 
Fig. 2. Optical diffractogram of a gyrase B subumt two-dimenslonal crystal. The unit cell parameters are: u = 6.1 nm, b -= 7.6 nm and 7 = 64”. 
Fig. 3. Two-dimensional symmetrized and contoured projection map of the gyrase B subum!, obtained through a Fourier synthesis using 12 terms 
up to I/2.7 nm-‘. Bar = 2 nm. 
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binds to novobiocin linked phospholipids and subse- 
quently is oriented in a plane. 
Crystallization experiments with novobiocin linked 
phospholipids and buffer A containing free novobiocin 
(0.3 mg/ml) competing with the derivatized lipids did 
not provide protein arrays any more, providing addi- 
tional evidence for the specific molecular recognition of 
the ligand by the protein on the Iipid monolayer. 
All novobiocin linked phospholipids (Ii-14 and 
111-11~) were experimented (about ten times each) and 
compared with regard to the quality of the protein ar- 
rays produced. Whatever the way novobiocin was link- 
ed to the lipid (through the 3’ or 2’ ’ position), 
two-dimensional crystals were obtained, showing that 
in all cases the affinity of the protein for the modified 
drug was high enough. With derivative I3 however, the 
crystals obtained were definitely larger and contained 
less defaults than with other lipids. This observation 
brought to the fore the role of the length of the spacer 
between the lipid and the ligand specifically recognized 
by the protein. A shorter spacer (Ii, 12) would likely 
force the protein to penetrate the lipid monolayer to 
complex the drug, and subsequently introduce some 
disorder in the array. On the other hand, a too long 
spacer (14) could provide the bound protein with too 
much freedom and increases the possibility to have 
defaults in the crystal. 
Experiments with novobiocin linked phospholipids 
mixed with egg phosphatidyl ethanolamine, egg 
phosphatidyl choline, dioleoyl phosphatidyl 
ethanolamine or dioleoyl phosphatidyI choline in 
various ratios did not provide any two-dimensional ar- 
rays of the gyrase B subunit. These results are rather 
unexpected, due to the specific area of the lipids used 
that is far lower (about a hundred times) than that of 
the cross-section of the protein. Actually, we cannot 
propose any clear explanation for this phenomenon. It 
could be due to a modification of the environment 
(topology, local charge. . .) at the surface of the lipid 
film. This hypothesis assumes much importance for the 
two-dimensional crystallization technique of proteins 
and is actually under investigation. 
Addition to the protein solution of a 
nonhydrolyzable ATP derivative, APPNP 
(0.3 mg/ml), improved the quality of the crystalline ar- 
rays obtained. The presence of spermidine (3 mMf pro- 
vided comparable results. 
Fig. 1 shows an untilted electron image of a negative- 
ly stained two-dimensional crystal of gyrase B subunit. 
This patch was about 1.1 x 0.7 pm in extent and was 
crystalline over virtually its whole surface. 
The optical diffractogram of this ordered array is 
shown in Fig. 2. All sufficiently ordered arrays made 
from the gyrase B subunit showed the same optical dif- 
fraction pattern. The parameters of the unit cell 
measured from these patterns are a = 6.1 nm, b = 
7.6 nm and y = 64”. Diffraction to at least 2.7 nm was 
clearly observed. The phase origin of the diffraction 
peaks was refined to identify a possible two-fold sym- 
metry axis, perpendicular to the crystal plane. The 
phases were then close to 0 or 180°, consistent with pz 
symmetry. Fig. 3 shows a two-dimensional symmetriz- 
ed and contoured projection map, synthesized using 12 
reflections up to 112.7 nm-‘, with a mean phase 
residual of 7.6”. The protein looks like a bean with two 
asymmetrical lobes. The unit cell contains two gyrase B 
subunits, which is reminiscent of the AzB z structure of 
the full enzyme. The subunits are laid head to tail and 
connected together at two different points. 
The method of forming two-dimensional crystals of 
proteins has several advantages. It needs very low 
quantities of protein (a few micrograms are sufficient) 
and due to the highly specific binding of the protein to 
the derivatized lipids, it is quite possible to work with 
partially purified proteins. These points are especially 
important when working with a protein that is very 
scarce or difficult to purify. 
We showed by using novobiocin derivatized 
phospholipids especially designed for two-dimensional 
crystallization of DNA gyrase experiments, that the 
gyrase B subunit was specifically bound to the lipid 
monolayer and unequivocally oriented in the plane to 
form two-dimensional arrays. 
Attention is now directed towards getting tilted im- 
ages of the crystalline arrays and reconstructing the 
three-dimensional structure of the gyrase B subunit. In 
the same way, we are involved in two-dimensional 
crystallization of the reconstructed AzBz DNA gyrase. 
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